# ANI PHARMACEUTICALS INC (ANIP) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ANI PHARMACEUTICALS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ANIP/mda/fy2025/): filed 2026-02-27; accession 0001023024-26-000014 (https://www.sec.gov/Archives/edgar/data/1023024/000102302426000014/anip-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ANIP/mda/fy2024/): filed 2025-02-28; accession 0001023024-25-000015 (https://www.sec.gov/Archives/edgar/data/1023024/000102302425000015/anip-20241231.htm)
- [FY 2023 MD&A](/company/ANIP/mda/fy2023/): filed 2024-02-29; accession 0001023024-24-000026 (https://www.sec.gov/Archives/edgar/data/1023024/000102302424000026/anip-20231231.htm)
- [FY 2022 MD&A](/company/ANIP/mda/fy2022/): filed 2023-03-09; accession 0001023024-23-000005 (https://www.sec.gov/Archives/edgar/data/1023024/000102302423000005/anip-20221231x10k.htm)
- [FY 2021 MD&A](/company/ANIP/mda/fy2021/): filed 2022-03-15; accession 0001023024-22-000004 (https://www.sec.gov/Archives/edgar/data/1023024/000102302422000004/anip-20211231x10k.htm)

Back to /company/ANIP/